Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - TOTAL OTHER INCOME
Total Other Income AVTX - Avalo Therapeutics, Inc.
-8.09 M
LAST VALUE
-83.13%
2 YEAR CAGR
-171.75%
5 YEAR CAGR
-53.61%
10 YEAR CAGR